NCT01459939View on ClinicalTrials.gov

A Double-blind, Randomized, Parallel Group, Fase III Comparative Study With Rose Hip Powder Powder and Placebo Given to Patients With Mild to Moderate Osteoarthritis in the Knee or/and Hip

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

May 31, 2012

Conditions
PainActivities of Daily LivingQuality of Life
Interventions
DIETARY_SUPPLEMENT

Rose-hip powder capsules

5 x 0,5 g rose-hip powder capsules BID the first 3 weeks and decreasing to 5 x 0,5 g QD the following 9 weeks

DIETARY_SUPPLEMENT

Placebo

5 x 0,5 g placebo powder capsules BID the first 3 weeks and decreasing to 5 x 0,5 g QD the following 9 weeks

Trial Locations (1)

8200

INCUBA Science Park - Skejby, Aarhus

All Listed Sponsors
lead

Hyben Vital ApS

INDUSTRY

NCT01459939 - A Double-blind, Randomized, Parallel Group, Fase III Comparative Study With Rose Hip Powder Powder and Placebo Given to Patients With Mild to Moderate Osteoarthritis in the Knee or/and Hip | Biotech Hunter | Biotech Hunter